Table 4.
Treatments |
||||||
---|---|---|---|---|---|---|
Items | CON | ANT | APS | GPS | SEM | P-value |
IgA (ng/mL) | 2.88b | 4.49a | 4.83a | 3.98a | 0.23 | 0.007 |
IgM (ng/mL) | 1.97b | 2.82a | 2.59a | 2.59a | 0.11 | 0.036 |
IgG (ng/mL) | 41.86c | 53.40bc | 79.72a | 65.03ab | 3.77 | <0.001 |
TNF-α (pg/mL) | 39.72a | 26.94b | 24.19b | 21.25b | 1.71 | <0.001 |
IL-1β (pg/mL) | 290.42a | 195.3b | 173.51b | 170.25b | 13.1 | <0.001 |
IL-6 (pg/mL) | 134.05a | 64.85b | 55.18b | 46.23b | 8.67 | <0.001 |
Means within a row with no common superscripts differ (P < 0.05).
Abbreviations: ANT, basal diet supplemented with 500 mg/kg terramycin calcium; APS, basal diet supplemented with 300 mg/kg Astragalus membranaceus polysaccharides; CON, control group with basal diet; GPS, basal diet supplemented with 150 mg/kg Glycyrrhiza uralensis polysaccharides; IgA, immunoglobulin A; IgM, immunoglobulin M; IgG, immunoglobulin G; TNF-α, tumor necrosis factor-α; IL-β, interleukin-1β; IL-6, interleukin-6; SEM, pooled standard error of the mean.